Induction Treatment of Proliferative Lupus Nephritis With Leflunomide Combined With Prednisone

PHASE2/PHASE3CompletedINTERVENTIONAL
Timeline

Start Date

October 31, 2002

Conditions
Nephritis, Lupus
Interventions
DRUG

leflunomide combined with prednisone

Trial Locations (8)

100034

Renal Division, Peking University First Hospital, Beijing

Unknown

Department of Nephrology, Kidney Center and key Lab of PLA, Chinese General Hospital of PLA, Beijing

Division of Nephrology, Nanfang Hospital, Southern Medical University, Guangzhou

Renal Division, the First Affiliated Hospital, Sun Yat-sen University, Guangzhou

Department of Rheumatology, the Second Affiliated Hospital, Harbin Medical University, Harbin

Department of Nephrology, Shanghai Changzheng Hospital, Shanghai

Renal Division, Huashan Hospital, Fudan University, Shanghai

Renal Division, Renji Hospital, Shanghai Jiaotong University, Shanghai

All Listed Sponsors
lead

Peking University

OTHER

NCT00268567 - Induction Treatment of Proliferative Lupus Nephritis With Leflunomide Combined With Prednisone | Biotech Hunter | Biotech Hunter